Ron Piervincenzi, Ph.D., CEO of United States Pharmacopeia, sits down with host, Rich Bendis, to discuss USP’s growth since his last visit, the nature of their organization, and plans on hosting the 2022 BioHealth Capital Region Forum in person at their beautiful building in Rockville, Maryland.

Listen now via Apple https://apple.co/3JpVTHB, Google https://bit.ly/3JnJfsI, Spotify https://spoti.fi/3JoLig7, and TuneIn https://bit.ly/3BhNcfE.

Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, visits Rich Bendis to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.

Listen now via Apple https://apple.co/3GztBZg, Google https://bit.ly/3gAfHvn, Spotify https://spoti.fi/3GBiaAm, and TuneIn https://bit.ly/3B54Y5V.

Dr. Geoffrey Lynn is leveraging his background in synthetic chemistry and cellular immunology to lead Avidea’s efforts to develop precision immunotherapies for treating cancer and autoimmune diseases. Dr. Lynn has expertise in designing, GMP manufacturing and assessing safety, efficacy & MOA of polymer-drug conjugate / nanoparticle technologies for immunotherapeutic applications. Previously, Dr. Lynn was a visiting scientist in the laboratory of Professor Christopher Jewell at the Fischell Department of Engineering at UMD and trained as a post-doctoral fellow with Dr. Robert Seder at the Vaccine Research Center of the National Institutes of Health (NIH). Dr. Lynn attended medical school at Johns Hopkins University; obtained a Ph.D. in Biomedical Engineering from the University of Oxford as an NIH-Oxford and National Science Foundation Graduate Research Fellow; and received his B.S. in chemistry from Elon University, where he was a Goldwater Scholar.

Read the Transcript

Bill visits BioTalk to talk about being a serial entrepreneur, biotech executive, and their recent acquisition of Avidea Technologies.

Listen now via Apple https://apple.co/3fTySQM, Google https://bit.ly/3KDPMkh, Spotify https://spoti.fi/3rI7UB3, Amazon https://amzn.to/33DwOtH, or TuneIn https://bit.ly/3fS8C9f.

Ellington West, CEO & Co-founder of Sonavi Labs, joins BioTalk to discuss their building the startup, their medical device, and raising funds in the BioHealth Capital Region.

Listen via Apple https://apple.co/3H25FPN, Google https://bit.ly/3kfXaXH, Spotify https://spoti.fi/3kgBLxI, and TuneIn https://bit.ly/3H43oU6.

Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF), joins BioTalk to discuss her career, investing in Maryland, and accelerating cures.

Listen via Apple https://apple.co/3ED5uIy, Google https://bit.ly/3EudFqG, Spotify https://spoti.fi/3EudHii, and TuneIn https://bit.ly/3bs9a3u.

Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME), joins Rich Bendis from the BHI Offices to discuss their biotech mission, their relationship with Maryland, and opportunities to expand in the United States

Listen now on Apple https://apple.co/2XGxg7i, Google https://bit.ly/3bbuDxz, Spotify https://spoti.fi/2XI5h7n, and TuneIn https://bit.ly/2XGwYNJ.

Listen now via Apple https://apple.co/3BSIFjn, Google https://bit.ly/3j7YyLt, Spotify https://spoti.fi/2Z474Ec, and TuneIn https://bit.ly/3DUweUz.

Divya Chadha Manek was appointed as the NIHR CRN’s Head of Commercial Business Development in 2015 then in 2020, Divya was seconded to the UK Vaccines Taskforce (VTF) which was set up in response to the COVID-19 pandemic to lead the UK’s search for a safe and effective vaccine. Divya was responsible for supporting global pharmaceutical companies to rapidly generate the evidence required for marketing authorisation of COVID-19 vaccines. Divya also played a pivotal role in conceptualising and developing the NHS Vaccine Research Registry.

Alex Philippidis, Senior Business Editor of Genetic Engineering and Biotechnology News, returned to the Forum to give his annual update on the GEN rankings of the Top 10 Bio Clusters in the United States. The BioHealth Capital Region is currently ranked #4 with a goal to be Top 3 by 2023 , and Alex briefly discusses each of the 10 top clusters and discuss how they have performed during the Pandemic. He also mentions the Up and Coming Regions of the Country.

Pete Briskman, Executive Managing Director and Co-Lead for the Mid-Atlantic Life Sciences Practice, follows Alex and does a deep dive into specifically the BioHealth Capital Region’s outstanding performance over the last year.

Watch now by visiting https://www.youtube.com/watch?v=oV6YjIGdIhg

Listen now via Google https://bit.ly/3EWtTtJ, Apple https://apple.co/3ocpP2w, Spotify https://spoti.fi/3EUALYu, and TuneIn https://bit.ly/3CGZ8Ho.

The session from the BioHealth Capital Region Forum focuses on a vision for a new science entity, the Advanced Research Projects Agency for Health (ARPA-H). This new NIH Institute would accelerate biomedical innovation and adoption of technologies and approaches to revolutionize healthcare and medicine. Tara A. Schwetz, Ph.D. is the Assistant Director for Biomedical Science Initiatives in the White House Office of Science and Technology Policy (OSTP). She is currently on detail to OSTP from her role as Associate Deputy Director (ADEPD), National Institutes of Health (NIH). During her tenure as ADEPD, Dr. Schwetz also served as the acting Director of the National Institute of Nursing Research (NINR). Prior to assuming these roles, she was the Chief of the Strategic Planning and Evaluation Branch in the Office of the Director at the National Institute of Allergy and Infectious Diseases (NIAID). Dr. Schwetz led several efforts while at NIAID, including conducting an evaluation of the Centers of Excellence for Influenza Research and Surveillance to facilitate evidence-based decision-making and developing the NIAID Strategic Plan for Tuberculosis Research. Previously, Dr. Schwetz served as the Senior Advisor to the Principal Deputy Director of NIH (DEPD), where she coordinated efforts such as Reimagine HHS, the NIH rigor and reproducibility activities, and the first NIH-Wide Strategic Plan. Dr. Schwetz also served in the dual role of the NIH Environmental influences on Child Health Outcomes (ECHO) Interim Associate Program Director and the Special Assistant to the DEPD. Prior to these roles, she was a Health Science Policy Analyst at the National Institute of Neurological Disorders and Stroke, where she helped develop the National Pain Strategy. Dr. Schwetz started her career at NIH as an AAAS Science and Technology Policy Fellow at NINR. She received a BS in biochemistry with honors from Florida State University and a PhD in biophysics from the University of South Florida, followed by a postdoctoral fellowship at Vanderbilt University.

Listen to the audio as Rich Bendis, President and CEO of BioHealth Innovation conducts a fireside chat with Dr. Anthony Fauci, Director of the National Institute for Allergy and Infectious Disease (NIAID) since 1984. Dr. Fauci oversees an annual budget of over $6 Billion and has advised 7 President’s on many domestic and global health issues. He has an extensive portfolio of basic and applied research to prevent, diagnose and treat many existing and emerging infectious diseases.

Listen now via Apple https://apple.co/3nNlHWH, Google https://bit.ly/3Ar0uoZ, and Spotify, https://spoti.fi/3ExxAWH

Dr. Xavier Barril, Chief Scientific Officer, Gain Therapeutics, and Hartaj Singh, Managing Director and Senior Analyst, Oppenheimer & Co. Inc., Join BioTalk to discuss Artificial Intelligence and Machine Learning in Drug Discovery Wall Street’s Views on this Exciting Science.

Listen Now via Apple https://apple.co/3z1rdqN, Google https://bit.ly/2X2pNPu, Spotify https://spoti.fi/2Vn2Ohx, and TuneIn https://bit.ly/38PJn41.

Lily Qi, Representative for the 15th legislative district in the Maryland House of Delegates. Joins BioTalk to discuss her career, Biotech in Montgomery County, and being a supporter of the BioHealth Capital Region

Listen now on Google https://bit.ly/3sW3iHE, Apple https://apple.co/3yvdkR4,  Spotify https://spoti.fi/3yxKRdw, TuneIn https://bit.ly/3zz8gww

Jeff Galvin, CEO of American Gene Technologies and Rich Bendis, CEO and President of BioHealth Innovation, Inc. have a fireside chat about the rapid evolution of the BioHealth Capital Region.

You can also listen to the audio only version via Apple https://apple.co/37wc6Kk, Google https://bit.ly/2XbLe0v, Spotify https://spoti.fi/3yCWhxE, and TuneIn https://bit.ly/3AqYkoR.

Click here to view the video interview between Jeff and Rich.

Paul Rennie OBE, Counsellor for Global Issues in the Global Economy Group at the British Embassy, Washington DC, and Professor Jason Snape, Head of Environmental Protection within AstraZeneca’s Global Sustainability Team, join Rich Bendis to Discuss Life Sciences, Climate Change, COP26 - UN Climate Change Conference, and The Race to Zero Campaign.

Listen now via Apple https://apple.co/3ls3EEp, Google https://bit.ly/3liTlSU, Spotify https://spoti.fi/3ylxair, and TuneIn https://bit.ly/3rS9Giz.

Jeff Boyle, President of Ellume USA, joins Rich Bendis on BioTalk to chat about his history, their Flagship U.S. Manufacturing Facility in Frederick, MD, and why BioHealth Capital Region is a right fit for their company goals.

Listen now on Google https://bit.ly/3i0XFUO, Apple https://apple.co/2TDD1kg, Spotify https://spoti.fi/3kWwP1P, and TuneIn https://bit.ly/3BGPDrP

Howard Carolan, Co-Founder and CEO  of CoapTech, Inc., and Neil Davis, Program Director of the Biomedical Entrepreneurship Graduate Certificate program at the University of Maryland Baltimore (UMB), joins Rich Bendis to discuss Startups, Tech Transfer, and the Funding.

Listen now on Google https://bit.ly/36fStWr, Apple https://apple.co/2UpA0UO, Spotify https://spoti.fi/36igrjG, and TuneIn https://bit.ly/3hpCRpT.

Mr. Davis is currently Program Director of the Biomedical Entrepreneurship graduate certificate program at the University of Maryland Baltimore (UMB).  This unique 12 credit graduate certificate provides the student with an opportunity to learn the process of creating valuable intellectual property (IP) and moving it into commercial application.  This process begins with the creation of IP, continues to its licensing and the formation of a venture through the growth of the venture, and culminates with the monetization of that venture.

Dr. Murat Kalayoglu, President and CEO at Cartesian Therapeutics, provides an update since his last visit on their cell and gene therapies, as well as fundraising successes.

Listen now on Apple https://apple.co/2SuVe2M, Google https://bit.ly/35Uq6wV, Spotify https://spoti.fi/3w3d7nd, or TuneIn https://bit.ly/2U9zYjL

Dr. Laurie E. Locascio, Vice President for Research at both the University of Maryland College Park and Baltimore, Visits BioTalk to Discuss Her Career, Tech Transfer, and the Two Institutions Working Together

Listen now on Apple https://apple.co/3oZKsNP, Google https://bit.ly/3vpYr1T, Spotify https://spoti.fi/2QZm3vd, and TuneIn https://bit.ly/2RQqs40.

Laurie E. Locascio, Ph.D., is the Vice President for Research at the University of Maryland, College Park and the University of Maryland, Baltimore.

Julie Lenzer, Chief Innovation Officer, The University of Maryland, joins Rich Bendis on BioTalk to discuss Ventures, Collaborations and growing the Quantum footprint in the BioHealth Capital Region.

Listen now via Apple https://apple.co/3on1a9C, Google https://bit.ly/3ovfj4M, Spotify https://spoti.fi/2Qn44hY, and TuneIn https://bit.ly/3w3Au0i.

Julie Lenzer is the Chief Innovation Officer at the University of Maryland and Acting Director for the newly-launched Quantum Startup Foundry. In these roles, she is charged with fostering and deploying innovation to drive economic and social impact from both university-affiliated and community based innovators. She currently oversees UM Ventures, the university’s tech transfer office, the Maryland Small Business Development Center (SBDC), the Maryland International Incubator (MI2), the Mixed/Augmented/Virtual Reality Innovation Center (MAVRIC), as well as university engagement with the Discovery District (UMD’s 150 acre research park). An active angel investor, she is also on the investment committee of the $10M Maryland Momentum Fund.

Rich Bendis welcomes Dr. Anne Khademian, Executive Director, The Universities at Shady Grove, on BioTalk to discuss Higher Ed in Montgomery County, their Biomedical Sciences and Engineering (BSE) facility, and Strategic Partnerships.

Listen now on Apple https://apple.co/3xYZG9P , Google https://bit.ly/3eyQ6mm, Spotify https://spoti.fi/3o4vztl, and TuneIn https://bit.ly/2SHbI7N.

Dr. Anne Khademian was named to serve as the Universities at Shady Grove’s third executive director in October 2020, following a nationwide search and her appointment to the post by Dr. Jay Perman, Chancellor of the University System of Maryland. As executive director of USG – a regional higher education center of USM in Montgomery County, with programs from nine universities on one campus – Dr. Khademian also holds the title of Associate Vice Chancellor for Academic Affairs for USM.

Gain Therapeutics CEO Eric Richman joins BioTalk to Discuss His Career, Redefining Drug Discovery, and Ventures in the BioHealth Capital Region and Beyond.

Listen now on Apple https://apple.co/3vB8mS3, Google https://bit.ly/2QI3xrb, Spotify https://spoti.fi/33021mT, and TuneIn https://bit.ly/2S7Yuk4.

Marina Massingham, CEO, Aifred Health, and Laurent Waessa, Senior Business Development Advisor, Québec Government Office in New York, join BioTalk to discuss their backgrounds, Ecosystems for Entrepreneurs, and how Quebec can find partnerships in the BioHealth Capital Region

Listen via Apple http://apple.co/3lfW7q5, Google http://bit.ly/3qJm2HP, Spotify http://spoti.fi/30LaoSc, and TuneIn http://bit.ly/30JHq4Z.

Dr. Dipanjan Pan and Phil Robilotto of the University of Maryland, Baltimore, join BioTalk to discuss RNA Disease Diagnostics, UM Ventures, and the commercialization of new medical technologies

Listen via Apple http://apple.co/3bsUsda, Google http://bit.ly/38l26Vd , Spotify http://spoti.fi/38kp9zu, and TuneIN http://bit.ly/2MVFqDp.

Alexandria Venture Investments Senior Associate, Conley Jones, virtually sits down with Rich Bendis on BioTalk to discuss Venture Trends, Investment Goals, and their National Footprint

Listen now on Apple http://apple.co/3sCbtaH, Google http://bit.ly/3kG3MgX, Spotify http://spoti.fi/3kKNGmt, and TuneIn http://bit.ly/3uGvJtJ.

Deka BioSciences CEO, John Mumm, CEO of Deka BioSciences, virtually guests on BioTalk to discuss his history in the BioHealth Capital Region, Precision Medicine, and Funding Strategies.

Listen now via Apple http://apple.co/3aIy6Ew, Google http://bit.ly/3sfEysd, Spotify http://spoti.fi/3aJq8ei, and Tunein http://bit.ly/2Me25ut.

Troy A LeMaile-Stovall, CEO and Executive Director of TEDCO, joins Rich Bendis BioTalk to discuss his background, the local ecosystem, and their vision for the future here in Maryland

Listen now via Apple http://apple.co/3tMsGQ4 , Google http://bit.ly/372QPs5 , http://spoti.fi/3tV2vXI , and TuneIn http://bit.ly/3aOuuzC.

Virginia Tech Corporate Research Center President and CEO, Brett Malone, Ph.D., joins Rich Bendis on BioTalk to discuss regional expansion plans, strategic partnerships, and success stories.

Listen now via Apple http://apple.co/3cPyW3t, Google http://bit.ly/3a1kP9m, Spotify http://spoti.fi/3cSwQ2Q, and TuneIn http://bit.ly/3a1kYJW

Amy Adams with George Mason University. Nikki Hastings with CvilleBioHub, and John Newby with Virginia Bio join Rich Bendis to discuss the new “Virginia Bio-Connect” statewide consortium and scale-Up initiative.

Listen now via Apple http://apple.co/39ZDl0M, Google http://bit.ly/3iRzmHO, Spotify https://spoti.fi/2MqHTVJ, and TuneIn http://bit.ly/2Yelr58. #innovation #biotalk #university #healthcare #digitalhealth #healthtech #research #biotech

Ronald T. Piervincenzi, Ph.D., Chief Executive Officer, United States Pharmacopeia virtually sits down with Rich Bendis to discuss the over 200 year old Organization, the services they offer, and their goals for the future.

Listen now on Google http://bit.ly/2NjX8As, Apple http://apple.co/3irukRQ, Spotify http://spoti.fi/35UfM8B, and TuneIn http://bit.ly/2XRFEgD.

While home in Kansas City for the season, BioTalk host Rich Bendis virtually sits down two local business leaders. Innar Health CEO, Chris Mathia, and Flyover Capital Managing Partner, Keith Molzer chat about the opportunities and challenges of BioHealth and Fund-Raising in Middle American.

Listen now via Google http://bit.ly/39ikNss, Apple http://apple.co/3shRRtk, Spotify http://spoti.fi/39ocgUz, and TuneIn http://bit.ly/2XvT0za.

Read more ...

Stu Solomon, President & CEO, Connected DMV joins BioTalk to discuss formation of the Strategic Renewal Task Force, their Covid-19 Pandemic Pivot, the Global Pandemic Prevention and Bioterrorism Center, and much more.

Listen now on Apple https://apple.co/3gqmJlB, Google https://bit.ly/3mVtled, Spotify https://spoti.fi/3mO0j05, and TuneIn https://bit.ly/37FMf2t.

Click here to read the transcript.

Listen now via Apple https://apple.co/374aOFI, Google https://bit.ly/3pTGqqj, Spotify https://bit.ly/3nIl7WO, and TuneIn https://bit.ly/3nIl7WO

Dr. Nacy co-founded our Sequella in 1997 and has served as our CEO and Chairman of the Board since 1999. Prior to Sequella, Dr. Nacy served during 1997 and 1998 as Chief Scientific Officer (CSO) for Anergen, Inc., a California company acquired by Corixa Corporation in December 1998. From 1993 through 1997, Dr. Nacy was Executive Vice President and CSO at EntreMed, Inc. and participated in its successful initial public offering in June 1996. Previously, Dr. Nacy was Career Scientist (GS-15) at the Walter Reed Army Institute of Research, Washington, DC. Dr. Nacy currently serves on the board of directors of companies and non-profit agencies.

Click here for the Transcript

Listen now on Apple https://apple.co/36iBbrp, Google https://bit.ly/32rZdiq, Spotify https://spoti.fi/2U7HEzs, and TuneIn https://bit.ly/3eOtb5i.

Praduman Jain, known to colleagues as “PJ,” is CEO and Founder of Vibrent Health and the Principal Investigator of the Participant Technology Systems Center of the National Institutes of Health Precision Medicine Initiative, the All of Us Research Program, for which the PTSC received a $75 million grant in 2017 and an additional award in 2020 with initial first-year funding of $39 million to build a national platform for health research and health management insights for 1 million people across the U.S. for at least 10 years.  Jain is also the Chair of the Security Board of the Committee on Access, Privacy & Security for the NIH All of Us Research Program; a member of the Roundtable on Genomics and Precision Health at the National Academies of Sciences, Engineering, and Medicine; an invited external expert for eMERGE & Beyond, The Future of Electronic Medical Records and Genomics program of the Division of Genomic Medicine, National Human Genome Research Institute; and an external advisory board member for iTHRIVE – a Virginia Clinical and Translational Science Award.

Scott Carmer, CEO of NexImmune, joins BioTalk to discuss his career in the BioHealth Capital Region, recent Milestones, and his Long-Term Vision for the company

Listen now via Apple https://apple.co/3kxdC3J, Google https://bit.ly/31FlUPB, Spotify https://spoti.fi/3kuVszD, or TuneIN https://bit.ly/2TqqD3f